HUE060112T2 - Eljárás biológiai kötõmolekula kiválasztására - Google Patents

Eljárás biológiai kötõmolekula kiválasztására

Info

Publication number
HUE060112T2
HUE060112T2 HUE19832930A HUE19832930A HUE060112T2 HU E060112 T2 HUE060112 T2 HU E060112T2 HU E19832930 A HUE19832930 A HU E19832930A HU E19832930 A HUE19832930 A HU E19832930A HU E060112 T2 HUE060112 T2 HU E060112T2
Authority
HU
Hungary
Prior art keywords
binding molecules
biological binding
selecting biological
selecting
molecules
Prior art date
Application number
HUE19832930A
Other languages
English (en)
Inventor
Holger Klapproth
Minden Marcus Duehren-Von
Original Assignee
Ava Lifescience Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ava Lifescience Gmbh filed Critical Ava Lifescience Gmbh
Publication of HUE060112T2 publication Critical patent/HUE060112T2/hu

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/5052—Cells of the immune system involving B-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HUE19832930A 2018-12-20 2019-12-19 Eljárás biológiai kötõmolekula kiválasztására HUE060112T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18000989 2018-12-20

Publications (1)

Publication Number Publication Date
HUE060112T2 true HUE060112T2 (hu) 2023-02-28

Family

ID=65033291

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE19832930A HUE060112T2 (hu) 2018-12-20 2019-12-19 Eljárás biológiai kötõmolekula kiválasztására

Country Status (9)

Country Link
US (1) US11644459B2 (hu)
EP (1) EP3899536B1 (hu)
JP (1) JP2022514423A (hu)
KR (1) KR20210106494A (hu)
CN (1) CN113260861B (hu)
CA (1) CA3123352A1 (hu)
ES (1) ES2929585T3 (hu)
HU (1) HUE060112T2 (hu)
WO (1) WO2020127827A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023152204A1 (en) * 2022-02-10 2023-08-17 Ava Lifescience Gmbh Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll
EP4227321A1 (en) * 2022-02-10 2023-08-16 AVA Lifescience GmbH Antibodies targeting the b-cell receptor of chronic lymphocytic leukemia (cll) for use in treatment of cll

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001020A4 (en) * 1997-07-29 2005-03-02 Sumitomo Electric Industries NON-HUMAN PRE-B CELL RECEPTOR ANTIBODIES
AU2014357450B2 (en) * 2013-12-03 2019-10-03 Welt Bio-Molecular Pharmaceutical, Llc Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereof
CA2968457C (en) 2014-11-20 2023-12-05 Umc Utrecht Holding B.V. Use of antibodies for enrichment of engineered t cells with exogenous immune receptors and antibodies for use in depletion of engineered t cells
GB201604494D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
HUE055283T2 (hu) * 2018-03-19 2021-11-29 Ava Lifescience Gmbh Biológiailag kötõ molekulák kiválasztására szolgáló módszer
CN108794642A (zh) 2018-07-05 2018-11-13 宁波安诺柏德生物医药科技有限公司 一种嵌合抗原细胞受体及其应用

Also Published As

Publication number Publication date
ES2929585T3 (es) 2022-11-30
JP2022514423A (ja) 2022-02-10
EP3899536A1 (de) 2021-10-27
US11644459B2 (en) 2023-05-09
EP3899536B1 (de) 2022-08-10
US20220057396A1 (en) 2022-02-24
CA3123352A1 (en) 2020-06-25
WO2020127827A1 (de) 2020-06-25
KR20210106494A (ko) 2021-08-30
CN113260861B (zh) 2023-02-03
CN113260861A (zh) 2021-08-13

Similar Documents

Publication Publication Date Title
SG11202106666UA (en) Methods for rna analysis
IL275510A (en) Specific antigen-binding molecules-ROR1
IL281901A (en) Multivalent binding compounds based on IgM and IgA-Fc
IL277848A (en) HER2-targeting antigen-binding molecules containing 4-1BBL
IL274926A (en) Pyrazolopyrimidines with activity against respiratory syncytial virus
IL277472A (en) Nucleic acid molecules for pseudouridylation
GB201702091D0 (en) Specific binding molecules
GB201907242D0 (en) Dna methods etc ii
IL287555A (en) Binding molecules
IL286013A (en) cd3 binding molecules
GB201811408D0 (en) CD137 Binding Molecules
GB201821206D0 (en) Analytical methods
HUE060112T2 (hu) Eljárás biológiai kötõmolekula kiválasztására
GB201901305D0 (en) Specific binding molecules
IL284317A (en) FAB pseudoproteins are multispecific binding proteins
EP3459754A4 (en) BOOK BINDING DEVICE
GB201910777D0 (en) Analytical method
EP3781204A4 (en) BINDING MOLECULES
EP3711967A4 (en) BINDING PROCESS FOR A BOND BY GLUE BOOKLET
IL288561A (en) gal9-binding molecules with immunosuppressive activity
IL288562A (en) Activating gal9 binding molecules
HUE055283T2 (hu) Biológiailag kötõ molekulák kiválasztására szolgáló módszer
GB201906118D0 (en) Anti-LAG-3 binding molecules
EP3781732A4 (en) DNA BRIDGE METHOD OF INCORPORATING DNA MOLECULES
GB201803178D0 (en) Specific binding molecules for htert